Skip to main content
. 2015 Nov 27;8(1):1–2. doi: 10.15252/emmm.201505943

Figure 1. Two different signaling pathways leading to EndMT .

Figure 1

The loss of either CCM (left) or FGFR1 (right) leads to EndMT via two distinctly different pathways converging on activation of KLF4/Smad‐dependent transcription of the mesenchymal program.